Abstract
Anticancer drugs based on molecular adducts of platinum and arsenic (arsenoplatins) show an unanticipated structure, substitution chemistry, and cellular cytotoxicity. The PtII-AsIII bonds in these complexes are stable in aqueous solution and strongly influence the lability of the trans ligand.
Original language | English (US) |
---|---|
Pages (from-to) | 10749-10752 |
Number of pages | 4 |
Journal | Angewandte Chemie - International Edition |
Volume | 52 |
Issue number | 41 |
DOIs | |
State | Published - Oct 4 2013 |
Externally published | Yes |
Keywords
- X-ray diffraction
- antitumor agents
- arsenic
- drug design
- platinum
ASJC Scopus subject areas
- Catalysis
- Chemistry(all)